Drug Type Small molecule drug |
Synonyms Deferitrin (USAN/INN), Iron chelator (Sanofi), GT 56-252 + [2] |
Target- |
Action- |
Mechanism Chelating agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC11H11NO4S |
InChIKeyOEUUFNIKLCFNLN-LLVKDONJSA-N |
CAS Registry239101-33-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Beta-Thalassemia | Phase 2 | United States | 01 Sep 2003 | |
| Iron Overload | Phase 2 | United States | 01 Sep 2003 | |
| Thalassemia | Phase 2 | - | - |





